UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple-negative breast cancer

Japanese journal of clinical oncology, 2022-10, Vol.52 (10), p.1167-1175

2022

Volltextzugriff (PDF)

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Cancer Immunology, Immunotherapy, 2023-04, Vol.72 (4), p.851-864

2023

Volltextzugriff (PDF)

Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer

Breast cancer (Tokyo, Japan), 2017-01, Vol.24 (1), p.63-68

2017

Volltextzugriff (PDF)

Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer

Breast cancer (Tokyo, Japan), 2017-01, Vol.24 (1), p.92-97

2017

Volltextzugriff (PDF)

Significance of PDL1 positive in TNBC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12557-e12557

2020

Volltextzugriff (PDF)

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Cancer Immunology, Immunotherapy, 2023-04, Vol.72 (4), p.851-864

2023

Volltextzugriff (PDF)

Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.627-637

2019

Volltextzugriff (PDF)

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest ™ 95GC Breast in a multi‑institutional registry study

Oncology letters, 2023-05, Vol.25 (5), p.1, Article 209

2023

Volltextzugriff (PDF)

Analysis of the Side Effects of Docetaxel with Cyclophosphamide (TC Therapy)

Gan to kagaku ryoho, 2015-06, Vol.42 (6), p.709

2015

Volltextzugriff (PDF)

Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2- primary breast cancer

Journal of clinical oncology, 2014-09, Vol.32 (26_suppl), p.141-141

2014

Volltextzugriff (PDF)

New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography

Journal of gastroenterology, 2014-04, Vol.49 (4), p.755-763

2014

Volltextzugriff (PDF)

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

Hypertension (Dallas, Tex. 1979), 2008-09, Vol.52 (3), p.563-572

2008

Volltextzugriff (PDF)

Sarcopenia as a predictive factor for febrile neutropenia during induction chemotherapy in head and neck squamous cell cancer

Auris, nasus, larynx, 2024-12, Vol.51 (6), p.971-975

2024

Volltextzugriff (PDF)

Risk analysis and rapid detection of the genus Thermoascus, food spoilage fungi

Food control, 2014-07, Vol.41, p.7-12

2014

Volltextzugriff (PDF)

Addition of Eplerenone to an Angiotensin-Converting Enzyme Inhibitor Effectively Improves Nitric Oxide Bioavailability

Hypertension (Dallas, Tex. 1979), 2008-03, Vol.51 (3), p.734-741

2008

Volltextzugriff (PDF)

Functional characterization of a cactus homolog from the silkworm Bombyx mori

Bioscience, biotechnology, and biochemistry, 2009-12, Vol.73 (12), p.2665-2670

2009

Volltextzugriff (PDF)

Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits

Hypertension research, 2008-03, Vol.31 (3), p.575-584

2008

Volltextzugriff (PDF)

First evaluation of real-time nitric oxide changes in the coronary circulation in patients with non-ischaemic dilated cardiomyopathy using a catheter-type sensor

European heart journal, 2010-12, Vol.31 (23), p.2862-2870

2010

Volltextzugriff (PDF)

Effects of Angiotensin II on NO Bioavailability Evaluated Using a Catheter-Type NO Sensor

Hypertension (Dallas, Tex. 1979), 2006-12, Vol.48 (6), p.1058-1065

2006

Volltextzugriff (PDF)

Effect of Pioglitazone on Nitroglycerin-Induced Impairment of Nitric Oxide Bioavailability by a Catheter-Type Nitric Oxide Sensor

Circulation Journal, 2008, Vol.72(6), pp.998-1002

2008

Volltextzugriff (PDF)

Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-γ-modulating activity, on nitric oxide bioavailability and atherosclerotic change

Journal of hypertension, 2008-05, Vol.26 (5), p.964-972

2008

Volltextzugriff (PDF)

Combined Effects of an 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor and Angiotensin II Receptor Antagonist on Nitric Oxide Bioavailability and Atherosclerotic Change in Myocardial Infarction-Prone Watanabe Heritable Hyperlipidemic Rabbits

Hypertension research, 2008-06, Vol.31 (6), p.1199-1208

2008

Volltextzugriff (PDF)

Optical Odor Imaging by Fluorescence Probes

Journal of robotics and mechatronics, 2012-02, Vol.24 (1), p.47-54

2012

Volltextzugriff (PDF)

Evaluation of Pharmacological Modulation of Nitroglycerin-Induced Impairment of Nitric Oxide Bioavailability by a Catheter-Type Nitric Oxide Sensor

Circulation Journal, 2007, Vol.71(9), pp.1473-1479

2007

Volltextzugriff (PDF)

Effects of Pioglitazone on Nitric Oxide Bioavailability Measured Using a Catheter-Type Nitric Oxide Sensor in Angiotensin II−Infusion Rabbit

Hypertension research, 2008-01, Vol.31 (1), p.117-125

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(46)
Tagungsberichte
(1)

Sprache

Englisch
(36)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple-negative breast cancer

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer

Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer

Significance of PDL1 positive in TNBC

Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer

Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest ™ 95GC Breast in a multi‑institutional registry study

Analysis of the Side Effects of Docetaxel with Cyclophosphamide (TC Therapy)

Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2- primary breast cancer

New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

Sarcopenia as a predictive factor for febrile neutropenia during induction chemotherapy in head and neck squamous cell cancer

Risk analysis and rapid detection of the genus Thermoascus, food spoilage fungi

Addition of Eplerenone to an Angiotensin-Converting Enzyme Inhibitor Effectively Improves Nitric Oxide Bioavailability

Functional characterization of a cactus homolog from the silkworm Bombyx mori

Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits

First evaluation of real-time nitric oxide changes in the coronary circulation in patients with non-ischaemic dilated cardiomyopathy using a catheter-type sensor

Effects of Angiotensin II on NO Bioavailability Evaluated Using a Catheter-Type NO Sensor

Effect of Pioglitazone on Nitroglycerin-Induced Impairment of Nitric Oxide Bioavailability by a Catheter-Type Nitric Oxide Sensor

Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-γ-modulating activity, on nitric oxide bioavailability and atherosclerotic change

Combined Effects of an 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor and Angiotensin II Receptor Antagonist on Nitric Oxide Bioavailability and Atherosclerotic Change in Myocardial Infarction-Prone Watanabe Heritable Hyperlipidemic Rabbits

Optical Odor Imaging by Fluorescence Probes

Evaluation of Pharmacological Modulation of Nitroglycerin-Induced Impairment of Nitric Oxide Bioavailability by a Catheter-Type Nitric Oxide Sensor

Effects of Pioglitazone on Nitric Oxide Bioavailability Measured Using a Catheter-Type Nitric Oxide Sensor in Angiotensin II−Infusion Rabbit

Suchergebnisse filtern